isabelobrien, Author at European Medical Journal - Page 43 of 68

Spotlight: April 2024

Catch up on the top stories to come from the pharma industry over April, including new collaborations set to improve treatments for patients, the latest approvals and more.

Poor return on investment rates on the rise

The pharma industry’s ability to recoup costs on their drug development pipeline was in trouble, been is the downward spiral coming to an end? Read more.

Does pharma have the power to turn back time?

Finding a way to combat the negative effects of ageing could save healthcare systems millions. Learn whether ageing could be the next big pharma market to take the world by storm.

Orphan drugs face new pressures

The orphan drug market has seen robust growth over the past decade, but may face challenges in maintaining its trajectory due to evolving investor and payer preferences.

Roundtable: How can pharma close the gender health gap?

Robyn Widenmaier (GSK) and Tabetha Sundin (AstraZeneca) discuss whether bids to improve gender parity could be the ticket to change in women’s health.

Spotlight: March 2024

Catch up on March’s top pharma news, including companies slashing inhaler costs and new hope for the UK life sciences sector.

Say hello to EMJ GOLD!

Join us for the next chapter of GOLD as we launch on our new home here on the EMJ website, providing you with a one-stop-shop for all your healthcare content needs.

Spotlight: February 2024

GOLD looks back on some of the top pharma news stories from the past month, including new approvals, the latest appointments and departures in the industry and more.

HBA announces 2024 Woman of the Year

Alnylam’s Dr Yvonne Greenstreet is named Woman of the Year by the Healthcare Businesswomen’s Association

Spotlight: December 2023

Take a look at the top pharma news stories of the past month including projections for the years ahead, new investments, pricing negotiations and more.